Association study between BGLAP RS1800247-polymorphic variant and type 2 diabetes mellitus development among hypertensive and non-hypertensive Ukrainians
DOI:
https://doi.org/10.14739/2310-1210.2021.3.220651Keywords:
type 2 diabetes mellitus, hypertension, osteocalcin, single nucleotide polymorphism, TT-homozygote, TC-heterozygote, CC-homozygoteAbstract
The risk T2DM development depends on hereditary predisposition. According to the current data, skeleton enhances insulin gene expression in pancreatic β-cells as well as increases insulin sensitivity of adipocytes, myocytes and hepatocytes through the secretion of unOCN.
The aim. To analyze the link between rs1800247 SNP and T2DM occurrence depending on the AH presence, as well as association between rs1800247 and systolic, diastolic, pulse, mean blood pressure among patients with diabetes.
Materials and Methods. This study included 153 patients with diagnosed T2DM and 311 individuals without any carbohydrate metabolism disorders. Polymerase chain reaction-restriction fragment length polymorphism analysis (PCR-RFLP) was used for BGLAP rs1800247-genotyping. Logistic regression with interaction term “genotype × AH” was used to estimate the association between BGLAP rs1800247-genotypes and T2DM development under dominant, recessive, over-dominant and additive models of inheritance. Linear regression was performed to investigate the influence of minor C-allele on the arterial blood pressure. All calculations were performed using Statistical Package for the Social Sciences software (SPSS, version 22.0, Chicago, IL, USA). A value of P ˂ 0,05 was considered as significant.
Results. No association was found between rs1800247 single nucleotide polymorphism and T2DM development neither in AH patients, nor in subjects without AH (Paint b > 0,05). There was no impact of rs1800247 genotypes on systolic, diastolic, pulse and mean blood pressure among patients with T2DM (P > 0,05).
Conclusion. It was found the lack of association between rs1800247 SNP and T2DM development as well as blood pressure parameters. Further studies with extended groups of comparison are needed for the confirmation of results. This research was a part of the scientific project “Molecular-genetic and morphological features of lower limb tissues regeneration under conditions of chronic hyperglycemia” (0117U003926).References
Kassi, E., & Papavassiliou, A. G. (2008). A possible role of osteocalcin in the regulation of insulin secretion: human in vivo evidence? The Journal of Endocrinology, 199(2), 151-153. https://doi.org/10.1677/JOE-08-0294
Mizokami, A., Kawakubo-Yasukochi, T., & Hirata, M. (2017). Osteocalcin and its endocrine functions. Biochemical Pharmacology, 132, 1-8. https://doi.org/10.1016/j.bcp.2017.02.001
Liu, D. M., Mosialou, I., & Liu, J. M. (2018). Bone: Another potential target to treat, prevent and predict diabetes. Diabetes, Obesity and Metabolism, 20(8), 1817-1828. https://doi.org/10.1111/dom.13330
Fernández-Real, J. M., & Ricart, W. (2011). Osteocalcin: a new link between bone and energy metabolism. Some evolutionary clues. Current Opinion in Clinical Nutrition and Metabolic Care, 14(4), 360-366. https://doi.org/10.1097/MCO.0b013e328346df4e
Clemens, T. L., & Karsenty, G. (2011). The osteoblast: An insulin target cell controlling glucose homeostasis. The American Society for Bone and Mineral Research, 26(4), 677-680. https://doi.org/10.1002/jbmr.321
Pi, M., Kapoor, K., Ye, R., Nishimoto, S. K., Smith, J. C., Baudry, J., & Quarles, L. D. (2016). Evidence for Osteocalcin Binding and Activation of GPRC6A in β-Cells. Endocrinology, 157(5), 1866-1880. https://doi.org/10.1210/en.2015-2010
Liu, D. M., Guo, X. Z., Tong, H. J., Tao, B., Sun, L. H., Zhao, H. Y., Ning, G., & Liu, J. M. (2015). Association between osteocalcin and glucose metabolism: a meta-analysis. Osteoporosis International, 26(12), 2823-2833. https://doi.org/10.1007/s00198-015-3197-8
Ling, Y., Gao, X., Lin, H., Ma, H., Pan, B., & Gao, J. (2016). A common polymorphism rs1800247 in osteocalcin gene is associated with hypertension and diastolic blood pressure levels: the Shanghai Changfeng study. Journal of Human Hypertension, 30(11), 679-684. https://doi.org/10.1038/jhh.2016.16
Chumachenko, Y. D., Harbuzova, V. Y., & Ataman, A. V. (2019). Association Study between BGLAP Gene HindIII Polymorphism and Type 2 Diabetes Mellitus Development in Ukrainian Population. Journal of Diabetes Research, 2019, Article 9302636. https://doi.org/10.1155/2019/9302636
Darwish, L., Nguyen, M. M., Saleem, M., Eakin, K. A., Herrmann, N., Sugamori, K. S., Oh, P. I., Yang, P., Mitchell, J., Lanctôt, K. L., & Swardfager, W. (2019). Lower serum osteocalcin concentrations in patients with type 2 diabetes and relationships with vascular risk factors among patients with coronary artery disease. Journal of Diabetes and its Complications, 33(5), 390-397. https://doi.org/10.1016/j.jdiacomp.2019.01.003
Riquelme-Gallego, B., García-Molina, L., Cano-Ibáñez, N., Sánchez-Delgado, G., Andújar-Vera, F., García-Fontana, C., González-Salvatierra, S., García-Recio, E., Martínez-Ruiz, V., Bueno-Cavanillas, A., Muñoz-Torres, M., & García-Fontana, B. (2020). Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients. Scientific Reports, 10(1), Article 1840. https://doi.org/10.1038/s41598-020-58760-7
Kunutsor, S. K., Apekey, T. A., & Laukkanen, J. A. (2015). Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence. European Journal of Epidemiology, 30(8), 599-614. https://doi.org/10.1007/s10654-015-0058-x
Das, S. K., Sharma, N. K., & Elbein, S. C. (2010). Analysis of osteocalcin as a candidate gene for type 2 diabetes (T2D) and intermediate traits in Caucasians and African Americans. Disease Markers, 28(5), 281-286. https://doi.org/10.3233/DMA-2010-0701
Lin, X., Onda, D. A., Yang, C. H., Lewis, J. R., Levinger, I., & Loh, K. (2020). Roles of bone-derived hormones in type 2 diabetes and cardiovascular pathophysiology. Molecular Metabolism, 40, Article 101040. https://doi.org/10.1016/j.molmet.2020.101040
Xu, Y., Ma, X., Xiong, Q., Hu, X., Zhang, X., Yuan, Y., & Bao, Y. (2018). Association between serum osteocalcin level and blood pressure in a Chinese population. Blood Pressure, 27(2), 106-111. https://doi.org/10.1080/08037051.2017.1408005
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
